Biliary tract cancers, which include malignancies of the bile ducts and gallbladder, are rare but aggressive diseases often diagnosed at an advanced stage—either locally advanced or metastatic. In the US, approximately 8,000 cases of bile duct cancer (cholangiocarcinoma) and 4,700 cases of gallbladder cancer are diagnosed each year. Patients with biliary tract cancers face numerous challenges throughout their care journey, including delays in diagnosis, limited access to specialized care, and difficulties navigating the complexities of the health care system. These challenges are often compounded by the impact of social determinants of health.
Sources: American Cancer Society, World Cancer Research Fund
The Association of Cancer Care Centers (ACCC), in partnership with the Cholangiocarcinoma Foundation, presents a new 3-part ACCC Knowledge Series, Addressing Disparities in the Diagnosis and Treatment for Biliary Tract Cancers. This video series highlights strategies to reduce disparities in the diagnosis and management of biliary tract cancers, including cholangiocarcinoma. Designed for gastrointestinal oncology providers, the series offers practical tools to enhance diagnostic accuracy, guide evidence-based treatment selection (including assessment for surgical candidacy), and support coordinated, multidisciplinary care.